Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0527 Transporter Info | ||||
| Gene Name | SCN4A | ||||
| Protein Name | Voltage-gated sodium channel alpha Nav1.4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs80338792 | ||||
| Site of GPD | chr17:63943846 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>A / C>G / C>T | ||||
| Minor Allele Frequency | G=0.0000/1 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Flecainide | Drug Info | Myotonia | Correlated with the increased drug response in patients (compare with allele C) | [ 1] | |
| References | |||||
| 1 | Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy. Eur J Clin Pharmacol. 2013 Apr;69(4):1037-9. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.